Price (delayed)
$214.01
Market cap
$8.31B
P/E Ratio
563.18
Dividend/share
N/A
EPS
$0.38
Enterprise value
$8.25B
Penumbra, Inc., headquartered in Alameda, California, is a global healthcare company focused on innovative therapies. Penumbra designs, develops, manufactures and markets novel products and has a broad portfolio that addresses
There are no recent dividends present for PEN.
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified. Data from and Sharadar.